Latest filing published 06 Oct 2022 for Global Blood Therapeutics, Inc..
Philip A. Pizzo, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in ClearPoint Neuro, Inc. and Global Blood Therapeutics, Inc. We count 27 filings; the first trade dates from 28 June 2013 and the latest from 5 October 2022.
The open-market record consists of 4 sales worth €2.1M, with no purchase. The rest of the record consists of 17 share grants and 5 option exercises. 2022 to date brings no purchases and 1 sale.
Most recently, on 6 October 2022, the filings show a transaction in Global Blood Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations